Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Jan 29, 2015

29745_dirs_2015-01-29_3b490296-ac3a-4042-97ac-263b3064e277.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-12-31

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-29 Common Stock G 85 Disposed 34155 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3480 Indirect